CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-31 | ROBERTSON RUSSEL C Director | Grant or award | +1,668 | $22.85 | $38K | 128,253 |
| 2022-03-31 | Miller Steven D Director | Grant or award | +1,340 | $22.85 | $31K | 63,229 |
| 2022-03-31 | ICAHN BRETT Director | Grant or award | +1,340 | $22.85 | $31K | 13,107 |
| 2022-03-31 | DE SCHUTTER RICHARD U Director | Grant or award | +1,504 | $22.85 | $34K | 321,092 |
| 2022-03-31 | Paulson John Director | Grant or award | +1,340 | $22.85 | $31K | 86,629 |
| 2022-03-15 | Spurr Robert U.S. President-Pharma Business | Sale | −4,846 | $22.20 | $108K | 92,101 |
| 2022-03-10 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −839 | $22.56 | $19K | 162,240 |
| 2022-03-08 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Sale | −3,889 | $21.76 | $85K | 93,139 |
| 2022-03-03 | Spurr Robert U.S. President-Pharma Business | Shares withheld for taxes | −4,074 | $23.61 | $96K | 96,947 |
| 2022-03-03 | Munsch Frederick SVP, Controller and CAO | Shares withheld for taxes | −608 | $23.61 | $14K | 23,182 |
| 2022-03-03 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −6,926 | $23.61 | $164K | 163,079 |
| 2022-03-03 | Eldessouky Sam EVP & Chief Financial Officer | Shares withheld for taxes | −1,242 | $23.61 | $29K | 119,455 |
| 2022-03-03 | PAPA JOSEPH C CHAIRMAN & CEO | Shares withheld for taxes | −12,643 | $23.61 | $299K | 1,095,152 |
| 2022-03-03 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −4,074 | $23.61 | $96K | 97,028 |
| 2022-03-03 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −5,564 | $23.61 | $131K | 475,267 |
| 2022-03-02 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Sale | −11,077 | $23.37 | $259K | 101,102 |
| 2022-03-02 | APPIO THOMAS CEO, Pharma Business | Grant or award | +152,690 | 480,831 | ||
| 2022-03-02 | APPIO THOMAS CEO, Pharma Business | Grant or award · Non-Qualified Stock Options (right to purchase) | +565,330 | 565,330 | ||
| 2022-03-02 | Spurr Robert U.S. President-Pharma Business | Sale | −1,595 | $23.37 | $37K | 65,394 |
| 2022-03-02 | Spurr Robert U.S. President-Pharma Business | Grant or award | +35,627 | $24.17 | $861K | 101,021 |
Page 15 of 23 · 453 trades